Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Am J Transplant. 2020 Aug;20(8):2101-2112. doi: 10.1111/ajt.15825. Epub 2020 Mar 12.
Prioritization of highly sensitized (HS) candidates under the kidney allocation system (KAS) and growth of large, multicenter kidney-paired donation (KPD) clearinghouses have broadened the transplant modalities available to HS candidates. To quantify temporal trends in utilization of these modalities, we used SRTR data from 2009 to 2017 to study 39 907 adult HS (cPRA ≥ 80%) waitlisted candidates and 19 003 recipients. We used competing risks regression to quantify temporal trends in likelihood of DDKT, KPD, and non-KPD LDKT for HS candidates (Era 1: January 1, 2009-December 31, 2011; Era 2: January 1, 2012-December 3, 2014; Era 3: December 4, 2014-December 31, 2017). Although the likelihood of DDKT and KPD increased over time for all HS candidates (adjusted subhazard ratio [aSHR] Era 3 vs 1 for DDKT: 1.85 , P < .001 and for KPD: 2.20 , P < .001), the likelihood of non-KPD LDKT decreased (aSHR: 0.82 , P = .02). However, these changes affected HS recipients differently based on cPRA. Among recipients, more cPRA 98%-99.9% and 99.9%+ recipients underwent DDKT (96.2% in Era 3% vs 59.1% in Era 1 for cPRA 99.9%+), whereas fewer underwent non-KPD LDKT (1.9% vs 30.9%) or KPD (2.0% vs 10.0%). Although KAS increased DDKT likelihood for the most HS candidates, it also decreased the use of non-KPD LDKT to transplant cPRA 98%+ candidates.
在肾脏分配系统 (KAS) 下,对高度致敏 (HS) 候选者进行优先排序,以及大型、多中心肾配对捐赠 (KPD) 清算所的发展,拓宽了 HS 候选者可获得的移植方式。为了量化这些方式的利用的时间趋势,我们使用了 2009 年至 2017 年的 SRTR 数据,研究了 39907 名成年 HS(cPRA≥80%)候补者和 19003 名受者。我们使用竞争风险回归来量化 HS 候选者进行 DDKT、KPD 和非-KPD LDKT 的可能性的时间趋势(时代 1:2009 年 1 月 1 日-2011 年 12 月 31 日;时代 2:2012 年 1 月 1 日-2014 年 12 月 3 日;时代 3:2014 年 12 月 4 日-2017 年 12 月 31 日)。尽管所有 HS 候选者进行 DDKT 和 KPD 的可能性随着时间的推移而增加(调整后的亚危险比 [aSHR] 时代 3 与时代 1 相比,DDKT:1.85,P<0.001;KPD:2.20,P<0.001),但非-KPD LDKT 的可能性却降低了(aSHR:0.82,P=0.02)。然而,这些变化根据 cPRA 对 HS 受者的影响不同。在受者中,更多的 cPRA 98%-99.9%和 99.9%+受者进行了 DDKT(cPRA 99.9%+的 96.2%在时代 3%,而 59.1%在时代 1),而较少的进行了非-KPD LDKT(1.9%)或 KPD(2.0%)。尽管 KAS 增加了大多数 HS 候选者进行 DDKT 的可能性,但它也减少了非-KPD LDKT 用于移植 cPRA 98%+候选者的使用。